Enyo Pharma SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Enyo Pharma SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10942
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Enyo Pharma SA (Enyo Pharma) is a biopharmaceutical company that develops molecules modulating host functions for the treatment of acute and chronic viral infections. The company provides technology which develops tools combining biological experimentation and computational development to identify key cellular proteins controlling virus replication. It has constructed a database made up of a library of virus derived peptides for the discovery of new antiviral drugs. Enyo Pharma also carries out hits identification and drug candidate’s identification for viral infections, among others. The company has collaborations with the Infectiology Center of Lyonbiopole, Jean Merieux BSL-4 Laboratory and other international academic groups. Enyo Pharma is headquartered in Lyon, France.

Enyo Pharma SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enyo Pharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
ENYO Pharma Raises USD46.6 Million in Series B Venture Financing 10
Enyo Pharma Raises USD24 Million in Series A Financing 12
Partnerships 13
Enyo Pharma Enters into Agreement with Poxel 13
Licensing Agreements 14
Enyo Pharma Enters into Licensing Agreement with Edelris 14
ENYO Pharma Enters into Licensing Agreement with Poxel 15
Enyo Pharma SA – Key Competitors 16
Enyo Pharma SA – Key Employees 17
Enyo Pharma SA – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
May 11, 2017: ENYO Pharma Strengthens Its Business Team to Support International Growth 19
Clinical Trials 20
Oct 26, 2017: ENYO Pharma Opens a New Subsidiary in Australia as a New Managing Center for Clinical Trials 20
Jun 13, 2017: ENYO Pharma Announces Successful Completion of EYP001 First in Man Phase 1 Study 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Enyo Pharma SA, Pharmaceuticals & Healthcare, Key Facts 2
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enyo Pharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enyo Pharma SA, Deals By Therapy Area, 2012 to YTD 2018 8
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ENYO Pharma Raises USD46.6 Million in Series B Venture Financing 10
Enyo Pharma Raises USD24 Million in Series A Financing 12
Enyo Pharma Enters into Agreement with Poxel 13
Enyo Pharma Enters into Licensing Agreement with Edelris 14
ENYO Pharma Enters into Licensing Agreement with Poxel 15
Enyo Pharma SA, Key Competitors 16
Enyo Pharma SA, Key Employees 17

List of Figures
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Enyo Pharma SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Malaysian Pacific Industries Berhad (MPI):企業の財務・戦略的SWOT分析
    Malaysian Pacific Industries Berhad (MPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Parenteral Drug India Ltd (PDPL):企業の財務・戦略的SWOT分析
    Summary Parenteral Drug India Ltd (PDIL) is a healthcare company that manufactures pharmaceutical products. The company provides products such as solid and liquid orals, IV fluids, oncology products and anaesthesia products. It offers IV fluids such as carbohyrated and electrolytes; diuretics, dialy …
  • American Airlines Group Inc (AAL):企業の財務・戦略的SWOT分析
    American Airlines Group Inc (AAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Luigi Lavazza S.p.A.:企業の戦略・SWOT・財務情報
    Luigi Lavazza S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Luigi Lavazza S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Global Voice Group S.A.:企業の戦略的SWOT分析
    Global Voice Group S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • DaVita Inc (DVA):医療機器:M&Aディール及び事業提携情報
    Summary DaVita Inc (DaVita), formerly DaVita HealthCare Partners Inc., is a provider of dialysis services and integrated health care delivery and management services. The company is a provider of dialysis services in the US for patients with chronic kidney failure and end-stage renal disease (ESRD). …
  • CGN Power Co Ltd (1816):企業の財務・戦略的SWOT分析
    CGN Power Co Ltd (1816) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Tallgrass Energy Partners, LP (TEP)-石油・ガス分野:企業M&A・提携分析
    Summary Tallgrass Energy Partners, LP (Tallgrass Energy) is a midstream oil and gas company. It owns, operates, acquires and develops midstream energy assets in North America. The company offers natural gas transportation and storage services through its pipeline and natural gas processing assets to …
  • Aliancys AG:企業の戦略的SWOT分析
    Aliancys AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • GenMark Diagnostics Inc (GNMK):企業の製品パイプライン分析2018
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company provides products such as XT-8 systems and ePlex systems. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test …
  • Medeon Biodesign Inc (6499):医療機器:M&Aディール及び事業提携情報
    Summary Medeon Biodesign Inc (Medeon Biodesign) is a medical device company that develops patient-centered medical device products that address unmet medical needs. The company’s products include cardiovascular devices and equipment, devices for minimally invasive surgeries, laparoscopic device, hig …
  • Blueberry Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a provider of nano medicines for the treatment of dermatological disorders. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea pedis; BB2312 used for the treatment of Acne diseases, …
  • MannKind Corp (MNKD):製薬・医療:M&Aディール及び事業提携情報
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high …
  • Paymark:企業の戦略的SWOT分析
    Paymark - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • P/F Atlantic Petroleum (ATLA DKK):企業の財務・戦略的SWOT分析
    Summary P/F Atlantic Petroleum (Atlantic Petroleum) is an oil and gas company that offers development of offshore oil projects. The company's services include exploration, appraisal, development, and production programs. It operates its oil and gas interests in the Norwegian Continental Shelf, the U …
  • Daiwa House Industry Co., Ltd. (1925):企業の財務・戦略的SWOT分析
    Daiwa House Industry Co., Ltd. (1925) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • India Glycols Ltd (INDIAGLYCO):企業の財務・戦略的SWOT分析
    India Glycols Ltd (INDIAGLYCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Midea Group Co Ltd:戦略・SWOT・企業財務分析
    Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Neuronetics Inc (STIM):医療機器:M&Aディール及び事業提携情報
    Summary Neuronetics Inc (Neuronetics) is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders. The company provides neurostar TMS therapy system used to treat patients with depressive disorder. Its neurostar TMS components comprise practice data ma …
  • Taylor Wimpey Plc:戦略・SWOT・企業財務分析
    Taylor Wimpey Plc - Strategy, SWOT and Corporate Finance Report Summary Taylor Wimpey Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆